A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P Meeting Abstract


Authors: Aghajanian, C.; Filiaci, V. L.; Dizon, D. S.; Carlson, J.; Powell, M. A.; Secord, A. A.; Tewari, K. S.; Bender, D.; O'Malley, D. M.; Stuckey, A.; Rotmensch, J.; Levine, D. A.; Lankes, H. A.; Moore, K. N.
Abstract Title: A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901158
PROVIDER: wos
Notes: Meeting Abstract: 5500 -- Source: Wos